Risedronate and cerebral haemorrhage 
Risedronate and cerebral haemorrhage Patient Reports February 12, 2012
Risedronate Side Effects Report #5413265-4
Risedronate side effect was reported by a Physician from JAPAN on July 26, 2007. Female patient, 76 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: cerebral haemorrhage. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with KIPRES, HUSTAZOL, MUCOSOLVAN, NIVADIL, LIVALO, ASPARA. Patient recovered.Risedronate Side Effects Report #5467312-4
Risedronate side effect was reported by a Physician from JAPAN on Sept 06, 2007. Female patient, 76 years of age, was diagnosed with osteoporosis
and was treated with Risedronate. After drug was administered, patient experienced the following side effects: cerebral haemorrhage. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with KIPRESS, HUSTAZOL, MUCOSOLVAN, NIVADIL, LIVALO, ASPARA, TIZANIDINE. Patient was hospitalized and became disabled. Patient recovered.Risedronate Side Effects Report #5930352-2
Risedronate side effect was reported by a Physician from JAPAN on Oct 08, 2008. Male patient, 67 years of age, was diagnosed with osteitis deformans, congestive cardiomyopathy and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood calcium decreased, cerebral haemorrhage, cerebral infarction. Risedronate dosage: 17.5MG ONCE DAILY, ORAL. During the same period patient was treated with WARFARIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Risedronate Side Effects Report #5914551-1
Risedronate side effect was reported by a Physician from JAPAN on Sept 24, 2008. Female patient was diagnosed with osteitis deformans and was treated with Risedronate. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction. Risedronate dosage: 17.5 MG REGIMEN, ORAL. Patient recovered.